Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Updated Overall Survival Data and Biomarker Results from Sintilimab ORIENT-11 Study in First-Line Nonsquamous Non-Small Cell Lung Cancer Published in the Journal of Thoracic Oncology 2021-08-06 08:00
Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination 2021-08-06 05:03
Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Vaccine 2021-08-06 04:41
Advanced Instruments to Acquire Solentim, a Trusted Global Leader in Cell Imaging for Cell Line Development and Clone Characterization 2021-08-06 02:00
Brii Biosciences Announces the Completion of Enrollment in the Phase 3 National Institutes of Health (NIH) ACTIV-2 Trial, Evaluating the BRII-196 and BRII-198 Monoclonal Neutralizing Antibody Combination for the Treatment of COVID-19 2021-08-05 22:46
ArisGlobal Lauded by Frost & Sullivan for Enabling Life Sciences Companies to Accelerate R&D with Its LifeSphere® Platform 2021-08-05 21:55
China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval 2021-08-05 21:00
Berry Oncology Completes Series B1 Funding, Attracting Most Venture Capital to Date in Early Cancer Screening Sector 2021-08-05 21:00
Insilico Medicine and Usynova Announce Strategic Partnership on Accelerating R&D of Small Molecule Innovative Drugs with AI 2021-08-05 18:23
Pharmaxis Cancer Drug Decreases Tumour Burden in Pre Clinical Liver Cancer Model 2021-08-05 18:00
CUHK Discovers Children with Autism Have Delayed Gut Microbiome Maturity and Identifies Faecal Bacterial Markers for Autism 2021-08-05 16:40
KYOWA Pharmaceutical Industry Co. Ltd. Partners with Bora Pharmaceuticals to Manufacture Generic Product for Filing in Japan 2021-08-05 14:50
Inmagene and Kissei Enter into an Exclusive License Agreement for Fostamatinib in China 2021-08-05 14:00
Everest Medicines Announces Approval of Clinical Trial Application by China NMPA for Phase 3 Trial of Xerava(TM) for Community-Acquired Bacterial Pneumonia 2021-08-05 13:12
Chinese Multinational Technology Company, HUAWEI, Aligns With Singapore-Based Healthtech Start-up PLANO to Tackle the Global Problem of Myopia 2021-08-05 10:00
Over 3,000 units of HFNC delivered to Poland and Peru, Micomme Medical helps the world fight against COVID-19 pandemic 2021-08-05 09:55
A New Approach to Dealing With Shortsightedness (Myopia) & Dry Eye in Children 2021-08-05 08:00
Wealth Dynamix Wins 'XCelent Functionality Award' in New Wealth Management CRM Report 2021-08-05 06:58
ABL Bio Receives IND Approval for Phase 1 Clinical Trial of ABL501, an anti-LAG-3/PD-L1 Bispecific Antibody 2021-08-04 21:30
Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine 2021-08-04 21:10
1 363 364 365 366 367 896